Logan Lutton

Skin cells can actively help the rabies virus multiply and pass into nearby nerve cells, explaining how even small bites or scratches, particularly from bats, can lead to infection.

The FDA has approved Merck’s once-daily single-tablet HIV treatment Idvynso (doravirine/islatravir) for virologically suppressed adults, based on phase 3 trials showing high rates of maintained viral suppression and generally manageable safety outcomes.

A study in JAMA Dermatology found that people using an AI tool were more accurate and confident in identifying skin conditions than those using standard methods, though it did not improve their understanding of next steps for care.

The Pharmacy Quality Alliance recognized 10 out of 613 Medicare Part D plans for exceptional or improved medication quality based on Centers for Medicare & Medicaid Services Star Ratings.

Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains the evolution of HIV PrEP from daily oral medications to long-acting injectables and how health policy and payer strategies can improve access, adherence and outcomes.

In this interview, Luis Ortiz, M.D., explains the current and emerging therapies for narcolepsy type 1 treatment.

In this interview, Luis Ortiz, M.D., explains how burdensome a narcolepsy diagnosis can be for a patient and why listening to their experiences helps shape new guidelines and treatments.

Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains how managed care organizations can support patients at risk of HIV.

Data from an automated refill reminder program identified key patient behaviors and characteristics that strongly predict medication nonadherence, which could enable more targeted interventions by health plans in the future.

From 2023 to 2024, the number of uninsured people in the United States rose for the first time since 2019, mainly because pandemic-era Medicaid protections ended, eligibility checks resumed and many people could not afford or access alternative coverage, according to a new issue brief from KFF.

In this interview, Luis Ortiz, M.D., explains how narcolepsy type 1 is now diagnosed and how it differs from type 2.

A large study of more than 780,000 adolescents found that atopic dermatitis is not associated with lower academic performance on national exams in Denmark or England.

Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains where managed healthcare organizations should look if they want to improve PrEP access and align with public health goals.

In this video interview, Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, provides an overview of the HIV preventative medicine landscape.

Adults in rural Appalachian Kentucky are facing a severe sleep crisis when compared to the rest of the country, a trend exacerbated by income inequality

Per- and polyfluoroalkyl substances seem to be associated with a high risk of reduced fertility, as well as maternal health concerns such as preeclampsia and gestational diabetes.

Nearly all U.S. adolescents who are at risk for HIV are missing out on preexposure prophylaxis, with significant disparities in access based on age, gender and geographic location.

New research suggests that when adolescents sleep, not just how long, may play a significant role in shaping their eating habits and activity levels, particularly during the school year.

Dermatology performance measures need to be streamlined and redesigned to better capture meaningful patient outcomes while reducing administrative burden and aligning with value-based care.

Women who experience menopause before age 40 face a significantly higher risk of coronary heart disease, according to new research by researchers at Northwestern Medicine.

Doctors Without Borders has accused Gilead of restricting access to its HIV prevention drug lenacapavir by refusing humanitarian sales and limiting supply, arguing this is hindering global efforts to expand HIV prevention in high-need regions.

Alkermes has initiated a phase 3 clinical program evaluating alixorexton for narcolepsy type 1 and type 2, with additional development underway for idiopathic hypersomnia.

Incyte’s phase 3 STOP-HS data show that povorcitinib improved symptoms of moderate to severe hidradenitis suppurativa in most patients over 54 weeks with a generally well-tolerated safety profile.

Sunlight can be both harmful and beneficial, meaning it’s important for dermatologists to give personalized advice to each patient, according to this morning’s 2026 American Academy of Dermatology session

Arthropods can cause or mimic a wide range of skin diseases, making accurate recognition, diagnosis and management essential in dermatologic care.

This afternoon’s session emphasized evolving vitiligo management strategies focused on emerging immune-targeted treatments, alongside a growing emphasis on holistic, patient-centered care.

At the American Academy of Dermatology 2026 meeting, dermatology leaders emphasized the growing need for advocacy to address rural access disparities and the escalating impact of climate change on patient care and health systems.

The 2026 American Academy of Dermatology meeting began today in Denver, featuring a keynote conversation this evening with John Legend on wellness, identity and his Loved01 skincare brand.

Vitiligo is a chronic autoimmune disease that affects skin pigmentation and, while not painful or contagious, requires greater attention in managed care due to its long-term nature and psychosocial impact.

A childhood teacher once told Rachel Moseley, Ph.D., there was “no point” in teaching her math. Since then, she has graduated from Cambridge University in England with a doctorate in cognitive neuroscience. She and a colleague have recently published a book of interviews exploring menopause among people with autism.